Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2014

  1. Renal effects induced by prolonged mPGES1 inhibition

    American Journal of Physiology - Renal Physiology, Vol. 306, Núm. 1

2013

  1. Leukotrienes, But not angiotensin II, are involved in the renal effects elicited by the prolonged cyclooxygenase-2 inhibition when sodium intake is low

    Journal of Cardiovascular Pharmacology, Vol. 61, Núm. 4, pp. 329-336